Point-of-Care Immunoassay Analyzer BD Veritor™ Plus CLIA Waived
CLIA-waived digital immunoassay for rapid detection of SARS-CoV-2, Flu A+B, RSV and Group A Strep
Product Specifications
Description
Advanced particle technology enhances sensitivity by using a proprietary process to produce highly stable, modifi ed colloidal metal particles, helping improve test performance
Adaptive read technology helps improve specificity to reduce false-positive results by compensating for background and non-specific binding
Fast and accurate assay performance
Prefilled color-coded unitized tubes by reagent facilitate workflow
Swab or liquid sample is inserted into unitized tube, processed and removed
Test device may be inserted immediately into Analyzer (Walk Away mode) or after incubation time is complete (Analyze Now mode)
Print-enabled through USB
Good for 10,000 tests or 24 months without maintenance or calibration